Continuous multilead ST-monitoring identifies patients with unstable coronary artery disease who benefit from
T Jernberg1, P Abrahamsson, B Lindahl
1Department of Cardiology, Cardiothoracic Center, University Hospital, Uppsala, Sweden.
European Heart Journal
|July 2, 2002
Summary
Multilead ST-monitoring identified patients with unstable coronary artery disease who benefit from extended anticoagulant therapy. Those with ischemic episodes showed reduced cardiac events with prolonged low-molecular weight heparin treatment.
Area of Science:
- Cardiology
- Clinical Trials
- Medical Monitoring
Background:
- Unstable coronary artery disease (CAD) poses a risk for cardiac events.
- Extended anticoagulant therapy may reduce these events.
- Multilead ST-segment monitoring can identify high-risk patients.
Purpose of the Study:
- To evaluate multilead ST-monitoring for identifying patients with unstable CAD who benefit from extended low-molecular weight heparin (LMWH).
- To assess the efficacy of prolonged LMWH treatment in patients identified by ST-monitoring.
Main Methods:
- A substudy of the FRISC II trial involving 629 unstable CAD patients.
- 24-hour continuous 12-lead ECG or vectorcardiography (ST-monitoring).
- Randomization to 3-month dalteparin (LMWH) or placebo after initial treatment.
Main Results:
- Ischemic episodes detected in 34% of patients during ST-monitoring.
- Extended dalteparin significantly reduced death, myocardial infarction, or revascularization in patients with ischemic episodes (35.2% vs 53.4%).
- No significant benefit of extended dalteparin was observed in patients without ischemic episodes.
Conclusions:
- Multilead ST-monitoring effectively identifies unstable CAD patients who benefit from extended anticoagulant therapy.
- Ischemic episodes detected during monitoring are key indicators for treatment response.
- This strategy aids in personalized anticoagulant treatment for unstable CAD.
Related Concept Videos
01:30Pulse rhythm
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...